| Primary |
| Diabetes Mellitus |
39.6% |
| Type 2 Diabetes Mellitus |
39.6% |
| Hypertension |
5.2% |
| Blood Glucose Increased |
2.0% |
| Depression |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Hyperlipidaemia |
1.6% |
| Anxiety |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Blood Glucose |
0.8% |
| Blood Pressure |
0.8% |
| Cardiac Disorder |
0.8% |
| Diabetes Mellitus Inadequate Control |
0.8% |
| Gastric Disorder |
0.8% |
| Hypersensitivity |
0.8% |
| Schizophrenia |
0.8% |
| Abdominal Pain |
0.4% |
| Back Pain |
0.4% |
| Bipolar Disorder |
0.4% |
| Blood Cholesterol Abnormal |
0.4% |
|
| Diarrhoea |
11.8% |
| Pancreatitis |
10.3% |
| Drug Ineffective |
6.4% |
| Gastrointestinal Disorder |
6.1% |
| Rash |
6.1% |
| Blood Glucose Increased |
5.8% |
| Abdominal Discomfort |
5.5% |
| Nausea |
5.5% |
| Vomiting |
5.2% |
| Medication Residue Present |
4.5% |
| Medication Residue |
4.2% |
| Pruritus |
3.9% |
| Headache |
3.6% |
| Dizziness |
3.3% |
| Myalgia |
3.3% |
| Abdominal Pain |
3.0% |
| Malaise |
3.0% |
| Weight Decreased |
3.0% |
| Constipation |
2.7% |
| Glycosylated Haemoglobin Increased |
2.7% |
|
| Secondary |
| Diabetes Mellitus |
33.3% |
| Type 2 Diabetes Mellitus |
21.2% |
| Product Used For Unknown Indication |
12.1% |
| Barrett's Oesophagus |
6.1% |
| Gastrooesophageal Reflux Disease |
6.1% |
| Blood Cholesterol Abnormal |
3.0% |
| Blood Glucose Increased |
3.0% |
| Diabetes Mellitus Inadequate Control |
3.0% |
| Glucose Tolerance Impaired |
3.0% |
| Glycosylated Haemoglobin Increased |
3.0% |
| Hypercholesterolaemia |
3.0% |
| Hypertension |
3.0% |
|
| Blood Glucose Increased |
10.8% |
| Drug Ineffective |
10.8% |
| Vomiting |
10.8% |
| Joint Swelling |
8.1% |
| Pancreatitis |
8.1% |
| Abdominal Pain Upper |
5.4% |
| Lipase Increased |
5.4% |
| Myalgia |
5.4% |
| Nausea |
5.4% |
| Bone Pain |
2.7% |
| Burning Mouth Syndrome |
2.7% |
| Diarrhoea |
2.7% |
| Feeling Hot |
2.7% |
| Haemorrhage |
2.7% |
| Hiatus Hernia |
2.7% |
| Incorrect Storage Of Drug |
2.7% |
| Injection Site Swelling |
2.7% |
| Jaundice |
2.7% |
| Medication Error |
2.7% |
| Medication Residue |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.0% |
| Type 2 Diabetes Mellitus |
12.9% |
| Diabetes Mellitus |
9.1% |
| Hypertension |
6.2% |
| Pain |
2.9% |
| Dry Eye |
2.4% |
| Asthma |
1.9% |
| Blood Pressure Abnormal |
1.9% |
| Fibromyalgia |
1.9% |
| Heart Disorder |
1.9% |
| Prophylaxis |
1.9% |
| Atrial Fibrillation |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Blood Pressure |
1.4% |
| Bursitis |
1.4% |
| Cardiac Disorder |
1.4% |
| Dyspepsia |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hypersensitivity |
1.4% |
| Migraine |
1.4% |
|
| Weight Decreased |
15.2% |
| Pain |
12.1% |
| Injection Site Haemorrhage |
9.1% |
| Death |
6.1% |
| Injection Site Reaction |
6.1% |
| Swollen Tongue |
6.1% |
| Vomiting |
6.1% |
| Acute Respiratory Distress Syndrome |
3.0% |
| Aphasia |
3.0% |
| Asthenia |
3.0% |
| Blood Glucose Increased |
3.0% |
| Cardiac Failure |
3.0% |
| Convulsion |
3.0% |
| Diabetes Mellitus |
3.0% |
| Drug Ineffective |
3.0% |
| Drug Interaction |
3.0% |
| Feeling Hot |
3.0% |
| Flushing |
3.0% |
| Herpes Simplex |
3.0% |
| Hospitalisation |
3.0% |
|
